An experimental in-vitro study to evaluate the anti-helicobacter activity of Glycyrrhetinic acid

1. Tonkic A, Tonkic M, Lehours P, Megraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 2012; 17:1-8. DOI: 10.1111/j.1523-5378.2012.00975.x10.1111/j.1523-5378.2012.00975.xOpen DOISearch in Google Scholar

2. Silva O, Viegas S, de Mello-Sampayo C, Costa MJ, Serrano R, Cabrita J, Gomes ET. Anti-Helicobacter pylori activity of terminalia macroptera root. Fitoterapia 2012; 83(5):872-6. DOI: 10.1016/j.fitote.2012.03.01910.1016/j.fitote.2012.03.019Open DOISearch in Google Scholar

3. Choi JH, Yang YJ, Bang CS, Lee JJ, Baik GH. Current Status of the third-line Helicobacter pylori eradication. Gastroenterol Res Pract. 2018; 2018:6523653. DOI: 10.1155/2018/652365310.1155/2018/6523653Open DOISearch in Google Scholar

4. Chen L, He J, Wang L, Ge Q, Chu H, Chen Y, et al. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China:an open-label, randomized clinical trial. Clin Exp Med. 2018 Jun 6. doi:10.1007/s10238-018-0510-9. [Epub ahead of print] DOI: 10.1007/s10238-018-0510-910.1007/s10238-018-0510-9.[Epubaheadofprint]DOI:10.1007/s10238-018-0510-9Open DOISearch in Google Scholar

5. Wu TS, Hu HM, Kuo FC, Kuo CH. Kaohsiung J. Eradication of Helicobacter pylori infection. Med Sci. 2014; 30(4):167-72. DOI: 10.1016/j.kjms.2013.11.00310.1016/j.kjms.2013.11.00324656156Open DOISearch in Google Scholar

6. Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance. Front Cell Infect Microbiol. 2017; 7:168. DOI: 10.3389/fcimb.2017.0016810.3389/fcimb.2017.00168541823728529929Open DOISearch in Google Scholar

7. O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection 2010. Helicobacter. 2010; Suppl 1:46-52. DOI: 10.1111/j.1523-5378.2010.00774.x10.1111/j.1523-5378.2010.00774.x21054653Open DOISearch in Google Scholar

8. Talebi Bezmin Abadi A, Yamaoka Y. Helicobacter pylori therapy and clinical perspective. J Glob Antimicrob Resist. 2018; pii:S2213-7165(18)30057-2.Search in Google Scholar

9. Amin M, Anwar F, Naz F, Mehmood T, Saari N. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules. 2013; 18(2):2135-49. DOI: 10.3390/molecules1802213510.3390/molecules18022135627035623434867Search in Google Scholar

10. Safavi M, Shams-Ardakani M, Foroumadi A. Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol. 2015; 53(7):939-60. DOI: 10.3109/13880209.2014.95283710.3109/13880209.2014.95283725430849Search in Google Scholar

11. Li K, Ji S, Song W, Kuang Y, Lin Y, Tang S, et al. Glycybridins A-K, bioactive Phenolic compounds from Glycyrrhiza glabra. J Nat Prod. 2017; 80(2):334-46. DOI: 10.1021/acs.jnatprod.6b0078310.1021/acs.jnatprod.6b0078328140583Open DOISearch in Google Scholar

12. Liu W, Sun Z, Qu J, Yang C, Zhang X, Wei X. Correlation between root respiration and the levels of bio-mass and glycyrrhizic acid in Glycyrrhiza uralensis. Exp Ther Med. 2017; 14(3):2323-8. DOI: 10.3892/etm.2017.472310.3892/etm.2017.4723560919928962162Search in Google Scholar

13. Kuang Y, Lin Y, Li K, Song W, Ji S, Qiao X, et al. Screening of hepatoprotective compounds from licorice against carbon tetrachloride and acetaminophen induced HepG2 cells injury. Phytomedicine. 2017; 34:59-66. DOI: 10.1016/j.phymed.2017.08.00510.1016/j.phymed.2017.08.00528899510Open DOISearch in Google Scholar

14. Mahmoud AM, Hussein OE, Hozayen WG, Abd El-Twab SM. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2:Protective effect of 18β-Glycyrrhetinic acid. Chem Biol Interact. 2017; 270:59-72. DOI: 10.1016/j.cbi.2017.04.00910.1016/j.cbi.2017.04.00928414158Open DOISearch in Google Scholar

15. Yoshida T, Abe K, Ikeda T, Matsushita T, Wake K, Sato T, et al. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury. Eur J Pharmacol. 2007; 576(1-3):136-42. DOI: 10.1016/j.ejphar.2007.08.01210.1016/j.ejphar.2007.08.01217825282Open DOISearch in Google Scholar

16. Fujii S, Morinaga O, Uto T, Nomura S, Shoyama Y. Development of double eastern blotting for major licorice components, glycyrrhizin and liquiritin for chemical quality control of licorice using anti-glycyrrhizin and anti-liquiritin monoclonal antibodies. J Agric Food Chem. 2016; 64(5):1087-93. DOI: 10.1021/acs.jafc.5b0473210.1021/acs.jafc.5b0473226765784Open DOISearch in Google Scholar

17. Fukazawa K, Seki M, Satoh K, Sugano K. Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test. Nihon Rinsho. 1999; 57(1):76-80.Search in Google Scholar

18. Owen RJ. Baillieres Clin Gastroenterol. Bacteriology of Helicobacter pylori. 1995; 9(3):415-46.10.1016/0950-3528(95)90041-1Search in Google Scholar

19. Marginean OC, Stolnicu S. New diagnostic perspectives related to Helicobacter pylori infection in children. Rev Romana Med Lab, 2009; 15(2):61-8.Search in Google Scholar

20. Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori:from culture to molecular biology. Helicobacter. 2007; Suppl 2:6-11. DOI: 10.1111/j.1523-5378.2007.00560.x10.1111/j.1523-5378.2007.00560.x17991170Open DOISearch in Google Scholar

21. O’Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World Journal of Gastroenterology 2005; 11:7499-507. DOI: 10.3748/wjg.v11.i47.749910.3748/wjg.v11.i47.7499472518416437723Open DOISearch in Google Scholar

22. Siddique O, Ovalle A, Siddique AS, Moss SF. Helicobacter pylori Infection:An update for the internist in the age of increasing global antibiotic resistance. Am J Med. 2018; 131(5):473-9. DOI: 10.1016/j.amjmed.2017.12.02410.1016/j.amjmed.2017.12.02429353050Open DOISearch in Google Scholar

23. Johnson KS, Ottemann KM. Colonization, localization, and inflammation:the roles of H. pylori chemotaxis in-vivo. Curr Opin Microbiol. 2018; 41:51-7. DOI: 10.1016/j.mib.2017.11.01910.1016/j.mib.2017.11.019586274929202336Open DOISearch in Google Scholar

24. Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016; 4:CD003840. DOI: 10.1002/14651858.CD003840.pub510.1002/14651858.CD003840.pub5716327827092708Open DOISearch in Google Scholar

25. Zhu Y, Zhou X, Wu J, Su J, Zhang G. Risk factors and prevalence of Helicobacter pylori infection in persistent high incidence area of gastric carcinoma in yangzhong city. Gastroenterol Res Pract. 2014; 2014:481365. DOI: 10.1155/2014/48136510.1155/2014/481365391444324550981Open DOISearch in Google Scholar

26. Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol. 2014; 20(3):684-98. DOI: 10.3748/wjg.v20.i3.68410.3748/wjg.v20.i3.684392147824574742Open DOISearch in Google Scholar

27. Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Dig Dis. 2014; 32(3):249-64. DOI: 10.1159/00035785810.1159/00035785824732191Open DOISearch in Google Scholar

28. Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014; 20(18):5461-73. DOI: 10.3748/wjg.v20.i18.546110.3748/wjg.v20.i18.5461401706124833876Open DOISearch in Google Scholar

29. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014; 345(2):196-202. DOI: 10.1016/j.canlet.2013.08.01610.1016/j.canlet.2013.08.01623981572Open DOISearch in Google Scholar

30. Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (Licorice):A Review. Phytother Res. 2017; 31(11):1635-50. DOI: 10.1002/ptr.589310.1002/ptr.589328833680Open DOISearch in Google Scholar

31. Hosseinzadeh H, Nassiri-Asl M. Pharmacological Effects of Glycyrrhiza spp. and Its Bioactive Constituents:Update and Review. Phytother Res. 2015; 29(12):1868-86. DOI: 10.1002/ptr.548710.1002/ptr.548726462981Open DOISearch in Google Scholar

32. Wei M, Ma Y, Liu Y, Zhou Y, Men L, Yue K, et al. Urinary metabolomics study on the anti-inflammation effects of flavonoids obtained from glycyrrhiza. J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1086:1-10. DOI: 10.1016/j.jchromb.2018.04.00710.1016/j.jchromb.2018.04.00729654981Open DOISearch in Google Scholar

33. Yang N, Patil S, Zhuge J, Wen MC, Bolleddula J, Doddaga S, et al. Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMI™, inhibit memory Th2 responses in vitro and in vivo. Phytother Res. 2013; 27(9):1381-91. DOI: 10.1002/ptr.486210.1002/ptr.4862359375523165939Open DOISearch in Google Scholar

34. Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat. 2003; 14(3):153-7. DOI: 10.1080/0954663031001436910.1080/0954663031001436914522625Open DOISearch in Google Scholar

35. Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, et al. Antiviral and antitumor activity of licorice root extracts. In-Vivo. 2016; 30(6):777-85. DOI: 10.21873/invivo.1099410.21873/invivo.1099427815461Search in Google Scholar

36. Pu JY, He L, Wu SY, Zhang P, Huang X. Anti-virus research of triterpenoids in licorice]. Bing Du Xue Bao. 2013; 29(6):673-9.Search in Google Scholar

37. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, et al. Antiviral effects of glycyrrhiza species. Phytother Res. 2008; 22(2):141-8. DOI: 10.1002/ptr.229510.1002/ptr.2295716797917886224Search in Google Scholar

38. Sabouri Ghannad M, Mohammadi A, Safiallahy S, Faradmal J, Azizi M, Ahmadvand Z. The effect of aqueous extract of glycyrrhiza glabra on Herpes simplex virus 1. Jundishapur J Microbiol. 2014; 7(7):e11616. DOI: 10.5812/jjm.1161610.5812/jjm.11616421658125368801Open DOISearch in Google Scholar

39. Kalaigandhi V, Poovendran P, Poogunran E. Antimicrobial activity of glycyrrhiza glabra (licorice) against peptic ulcer produced Helicobacter pylori. Int J Curr Pharm Res. 2011; 3(4):93-5.Search in Google Scholar

40. Raveendra KR, Jayachandra, Srinivasa V, Sushma KR, Allan JJ, Goudar KS, Shivaprasad HN, et al. An extract of Glycyrrhiza glabra (gutgard) alleviates symptoms of functional dyspepsia:a randomized, double-blind, placebo-controlled study. Evid Based Complement Alternat Med. 2012; 2012:216970. DOI: 10.1155/2012/21697010.1155/2012/216970312399121747893Search in Google Scholar

41. Memariani Z, Hajimahmoodi M, Minaee B, Khodagholi F, Yans A, Rahimi R, et al. Protective effect of polyherbal traditional formula consisting of Rosa damascena mill, Glycyrrhiza glabra L. and Nardostachys jatamansi DC., against ethanol-induced gastric ulcer. Iran J Pharm Res. 2017; 16(2):694-707.Search in Google Scholar

42. Asha MK, Debraj D, Prashanth D, Edwin JR, Srikanth HS, Muruganantham N, et al. In vitro anti-Helicobacter pylori activity of a flavonoid rich extract of Glycyrrhiza glabra and its probable mechanisms of action. J Ethnopharmacol. 2013; 145(2):581-6. DOI: 10.1016/j.jep.2012.11.03310.1016/j.jep.2012.11.03323220194Open DOISearch in Google Scholar

43. Wang Y, Wang S, Bao Y, Li T, Chang X, Yang G, et al. Multipathway Integrated adjustment mechanism of glycyrrhiza triterpenes curing gastric ulcer in rats. Pharmacogn Mag. 2017; 13(50):209-215. DOI: 10.4103/0973-1296.20455010.4103/0973-1296.204550542141428539709Open DOISearch in Google Scholar